Using a reverse phase protein microarray, up-regulated focal adhesion kinase (FAK) and mitogen-activated protein kinase 1 (MEK1) in plasma sEVs were identified as candidate biomarkers for BC diagnosis [40]. This evidence concerns the gene PTK2 and breast cancer.